A 22-year-old Japanese man was found to have bilateral hilar lymphadenopathy (BHL), and was diagnosed with sarcoidosis in 1995. He was followed without treatment until 2002, when a bone fracture due to osseous sarcoidosis was found in his left thumb. Despite systemic treatment with corticosteroid and methotrexate, a new bone lesion developed in his right foot and his right middle finger was fractured. The patient also suffered multiple organ involvements including brain and muscle lesions. This is the first report of a sarcoidosis patient who presented with BHL, and developed bone fractures after a long stable period of more than 5 years. 
Introduction
Sarcoidosis is a systemic granulomatous disease of unknown cause and the most commonly affected organ is the lung, followed by the lymph nodes, eyes, and skin. The frequency of osseous involvement of sarcoidosis is varied depending on race, ranging from 1 to 13% (1) . Almost any bone can be involved, and the short tubular bones of the hands and feet are most frequently affected (2) . Radiographical features include well-defined lytic defects and a lacework, reticulated pattern (3) . Osseous involvement occurs primarily in patients with chronic sarcoidosis with involvement of multiple organs (4) . Although bone lesions are often asymptomatic, the affected part may be tender and painful (2) . The frequency of bone fractures caused by osseous sarcoidosis is rare (2) , and only 12 cases have been reported to the best of our knowledge 2, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Here, we report a case of a patient with osseous sarcoidosis whose muscle, brain, and osseous involvement were detected 7 years after the first recognition of intrathoracic lesions. We focused on the osseous lesions which were multiple and refractory to the conventional treatment with corticosteroids and immunosuppressants.
Case Report
In October 1995, a 22-year-old Japanese man was found to have bilateral hilar lymphadenopathy (BHL) during his annual medical check-up. He visited a hospital where chest computed tomography (CT) was performed and mediastinal and hilar lymph node swelling accompanied by multiple small nodules of both lung fields were detected (Fig. 1A) . Transbronchial lung biopsy (TBLB) was performed, and he was histologically diagnosed with sarcoidosis. In this period, a gallium scintigram showed uptake only in the mediastinum and hilum. Extrathoracic lesions were absent, and he was followed-up without treatment for seven years without remarkable change of lung lesions. In February 2002, pain and swelling of the right middle finger and the left thumb developed, and a hand X-ray showed punch-out lesions of the phalanges of both fingers, and a bone fracture of the left thumb. In May 2002, a bone biopsy of the right middle finger was performed, which showed non-caseating epithelioid cell granulomas without evidence of fungal, or mycobacterial infections (Fig. 2) . Thus, he was diagnosed with osseous sarcoidosis, and admitted to our hospital in June 2002 for further investigations and treatment.
Physical examination revealed a body temperature of 37.4°C ; blood pressure was 118/62 mmHg, and pulse rate was 68/min with a regular rhythm. Swelling of the right middle finger and the left thumb was found. Bilateral post parotid (1 cm), inguinal (1 cm), and four sites of medial upper arm (3-4 cm) lymph node swelling was found. Lung and heart auscultations were normal, and abdominal and neurological examinations revealed no abnormality. The patient had no history of smoking or previous illnesses. The laboratory tests on admission (Table 1) showed no major abnormalities.
Arterial blood gas, pulmonary function tests, and electrocardiography revealed no abnormalities. Holter ECG detected biform paroxismal ventricular contractions (PVCs), thus echocardiography and thallium cardiac scintigraphy were performed to exclude cardiac involvement. Both tests revealed no abnormality. Bronchoalveolar lavage fluid showed an increased total cell recovery (2.93×10 5 /ml), with an increase in lymphocyte ratio (34.9%), and CD4/CD8 ratio (4.5).
Chest X-ray and CT on admission showed no remarkable change from the onset of the disease in 1995. Hand X-ray showed punch-out lesions in phalanges of the right middle finger and the left thumb with bone fracture of the left thumb (Fig. 3A) . 99m Tc bone scintigram showed uptakes in the right middle finger, the left thumb, and the left knee (Fig. 4) . However, there were no symptoms at the knee, and X-ray of knees revealed no abnormality. T1-weighted image of MRI of the left thumb showed decreased intensity of the bone marrows with thickening of surrounding connective tissues (Fig. 5) . A gallium scintigram showed uptakes on the mediastinum, hilum, fingers, the medial portion of bilateral arms, the right shoulder, and the left knee. MRI of shoulders and arms showed involvement of the right deltoid muscle and subcutaneous lymph node swelling of bilateral upper arms.
Based on these findings, the patient was diagnosed to have sarcoidosis with lung, bone (phalanges of the right middle finger and the left thumb), lymph node, and muscle involvement. Systemic treatment with corticosteroid (prednisolone, 35 mg/day) was started for treatment of destructive bone lesions in July 2002 ( Table 2 ). The swelling and pain of fingers improved shortly after the initiation of the treatment; however, punch-out lesions of fingers persisted. During the tapering of the steroid dosage, the patient complained of diplopia in November 2002. In December 2002, a brain MRI detected enhanced nodules at the pituitary stalk and the thalamus. Despite the diagnosis of concurrent neurosarcoidosis, diplopia was considered to be stable, thus the same dosage of prednisolone was continued. In February 2003, gallium scintigraphy was performed again, and an uptake in the right toe was detected. Despite the negative symptom of foot, an X-ray showed a punch-out lesion in a pediphalanx of the right hallux (Fig. 6 ). During the follow-up period, swelling and pain of the fingers recurred twice, thus methotrexate (6 mg/wk) was added in June 2003, and steroid dosage was increased to 20 mg/day in January 2004. Elcatonin was also administered weekly for the persistent bone lesions. Bone mineral density (BMD) was measured periodically, and in April 2004, there was no decrease in BMD. BHL and lung nodules showed improvement (Fig.  1B) , and lymph node swelling of the arms was almost completely resolved. Although slight improvement was found in the punch-out lesion of the left thumb, a new bone fracture of the phalanx of the right middle finger occurred in September 2004 (Fig. 3B ). Brain MRI was performed again in January 2004 and did not reveal any improvement in the brain lesions; the diplopia persisted until October 2004. As of the date of this report, the patient is still under the treatment with oral prednisolone (15 mg/day) and methotrexate (6 mg/wk) for the persistent osseous and brain lesions.
Discussion
We encountered a patient with osseous sarcoidosis accompanied by phalangeal bone fractures of both hands. Pediphalangeal bone was also involved, and he suffered from multiple organ involvement including the brain, lungs, muscles, and lymph nodes. Although young sarcoidosis patients who present with stage I disease (BHL without parenchymal involvement on chest X-ray) and no extrathoracic lesion generally have good prognoses (15) , the patient developed osseous and other multiple lesions after 7 years of stable disease. Previously reported cases of osseous sarcoidosis with bone fractures are summarized in Table 3 . None of the cases presented only with BHL, and this is the first case who presented with BHL and developed multiple bone fractures after a long stable period of more than 5 years. Based on the clinical course of this case, the possibility to develop multiple organ lesions cannot be excluded even when sarcoidosis patients present with BHL without any extrathoracic lesions, suggesting the necessity to monitor patients with persistent, stable stage I disease longitudinally (16) . The osseous lesions in this case presented with lytic lesions of the phalanges on hand X-ray. Previous reports of osseous sarcoidosis (2, 4) stated that the lesions were bilateral and developed after a long duration of the disease. Differential diagnosis of lytic lesions of the phalanges includes osteomyelitis, neoplasms, gout, and hyperthyroidism (3). When these conditions can be excluded in sarcoidosis patients, bone biopsies are not necessary to diagnose osseous sarcoidosis (3). However, bone biopsy is considered to be necessary when there is a solitary lesion, atypical in appearance, or it is the only manifestation of the disease. Shorr et al (17) evaluated the utility of the combination of bone scintigraphy and radiographs of the hands and feet to detect osseous sarcoidosis. They found that osseous involvements were present in 38.9% of patients with pulmonary sarcoidosis and musculoskeletal symptoms. They also found that bone scintigraphy and radiographs of the hands and feet were complementary; thus, they recommended performing both tests in sarcoidosis patients with musculoskeletal symptoms.
In the present case, an osseous lesion was also found in a pediphalanx. The lesion was asymptomatic and was not detected by the bone scintigraphy. These facts further stress the necessity to perform bone scintigraphy and radiographs of both hands and feet in sarcoidosis patients with the possibility to have osseous lesions. However, routine use of bone scintigraphy in patients with sarcoidosis is not recommended (18) . Serum 1,25 (OH)2 vitamin D, ionized calcium, and alkaline phosphatase (ALP) were normal on admission (Table 1) , although they seemed to be decreased because of the use of immunosuppressants and drugs that suppress bone resorption ( Table 2 ). Based on these findings, 1,25 (OH)2 vitamin D did not seem to play a major role in bone resorption in patients with osseous sarcoidosis (2). Ionized calcium and ALP levels might reflect bone resorption to some extent; however, they did not seem to be good markers of bone destruction because they were not elevated in this case. Among 12 previously reported cases of osseous sarcoidosis with bone fractures (Table 3 ), 6 cases were black patients, and there were no Japanese subjects. The number seemed to be compatible with the previous reports that showed the frequency of bone lesions to be higher in black patients (2) , and only 2% in Japanese patients (1) . Regarding the focus of bone fractures, the phalanges were the most frequently affected (5 cases), followed by the ulna (5-7), femur (7, 8) , metacarpus (9) and the rib (10); among these, 5 cases had multiple bone fractures. Although spontaneous healing can occur (11) , most cases were treated with steroids and/or surgery. In general, corticosteroids may control pain and swelling; however, such treatments are not considered to influence the course of osseous sarcoidosis (2) . According to the previous reports, careful excision of the affected lesions followed by reconstruction with bone grafts seemed to have good prognoses (5, 6, 12, 13) , whereas treatment with corticosteroids with or without fixation frequently resulted in non-union of the bones (5, 7, 12) . Adelaar reported a case of osseous sarcoidosis with phalangeal bone fracture that was progressive despite the excision of the lesion and placement of a bone graft (6) . In this case, the affected area was avascular on the arteriogram. The authors attributed the failure of the treatment with graft to avascularity of the lesion. On the other hand, Schuind et al reported that the affected area of osseous sarcoidosis with fractures was hypervascular (12) . The vascularity of affected areas might affect the efficacy of treatment with corticosteroids in patients with osseous sarcoidosis. In retrospect, surgical intervention was not indicated in the present case because the original lesion with bone fracture showed mild improvement during the followup period. However, treatment with corticosteroids and immunosuppressants seemed to be ineffective because of the appearance of a new fracture of the right middle finger. Based on the clinical course of this case and review of the literature, treatment with corticosteroid should be targeted to alleviate the pain and swelling of the lesions, and should be rapidly tapered when radiographic improvement does not occur, or if there is a decrease in bone mineral density, as a side effect of the treatment in patients with osseous sarcoidosis. However, recurrent pain and swelling of the lesions and other organ involvement may require prolonged treatment as in this case. In progressive cases with lytic bone lesions, surgery might be an option.
In conclusion, we report a case with osseous sarcoidosis who presented with BHL, and developed multiple bone fractures after a long stable period of more than 5 years. Treatment with corticosteroid and immunosuppressant seemed to be ineffective. Corticosteroids should be administered with caution considering the low response rate and the possibility to develop osteoporosis. Even in stable stage I disease, patients should be monitored periodically for the development of other organ involvement including bone lesions. 
